Informations générales (source: ClinicalTrials.gov)
Arterial Wall Calcium Load and Preferential Sites in Pseudoxanthoma Elasticum Versus Type 2 Diabetes and Chronic Kidney Disease. (Ca-Art-PXE2)
Observational
University Hospital, Angers (Voir sur ClinicalTrials)
janvier 2012
juillet 2013
29 juin 2024
Quantification and preferential sites of arterial wall calcification within the coronary
and lower legs arteries will be comared between Pseudo-Xanthoma elasticum(PXE) atients
and type 2 diabetics and Chronic Kidney disease.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| University Hospital - 49933 - Angers - Pays de la Loire - France | Ludovic MARTIN, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients with phenotypically and genotypically-proven PXE
- Type 2 diabetic patients with mediacalcosis (i.e. Ankle Brachial Index > 1.30)
- Patients with a chronic kidney disease (CKD), before kidney transplantation
- All patients should be affiliated to a Health care system
- Patients with phenotypically and genotypically-proven PXE
- Type 2 diabetic patients with mediacalcosis (i.e. Ankle Brachial Index > 1.30)
- Patients with a chronic kidney disease (CKD), before kidney transplantation
- All patients should be affiliated to a Health care system
- Patient with unproved PXE
- Patient under the age of 18 yrs
- Patient unwilling to participate to the study
- Pregnant women
- Patient not affiliated to a Health care system